Track Emerging Targets in Biopharma Research

Make better research and investment decisions. Identify promising protein and gene targets before they become mainstream.

What is SeqTrend?

SeqTrend aggregates and analyzes data from hundreds of scientific sources — validated by expert opinion globally — to help you identify emerging protein and gene targets with real potential.

Whether you're directing research, evaluating investments, or exploring new therapeutic areas, SeqTrend shows you what's gaining momentum and what's already too crowded.

Who is SeqTrend for?

Built for professionals who need to stay ahead in biotech innovation

Academic Researchers

PIs, postdocs, and senior researchers seeking new research directions, collaboration opportunities, and grant-worthy targets.

Life Science Professionals

Scientists and R&D teams in biotech and pharma tracking target validation, competitive landscapes, and emerging modalities.

Investors & Decision Makers

VCs, pharma executives, and BD teams evaluating investment opportunities and partnership targets in biopharma.

Identify Emerging Targets, Avoid Saturated Areas

Multi-source analysis to show you what's gaining momentum and what's already too competitive

Early Detection

Identify targets in the "emerging" phase before they hit mainstream attention and valuations skyrocket.

Multi-Source Analysis

Aggregate data from PubMed, clinical trials, patents, expert opinions, and biotech news in one place.

Trend Maturity Stages

Know if a target is emerging (opportunity) or established (crowded) with our maturity classification system.

Smart Alerts

Get notified when specific proteins or genes show acceleration in research activity or clinical progress.